Clareon Intraocular Lenses with the AutonoMe Delivery System

FDA Premarket Approval P190018 S008

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Implementation of new optical metrology equipment, gen-3 mtf system, to be used as part of the manufacturing process for clareon panoptix intraocular lenses at the alcon ireland manufacturing site

DeviceClareon Intraocular Lenses with the AutonoMe Delivery System
Generic NameIntraocular Lens
ApplicantAlcon Research, Ltd.
Date Received2020-10-30
Decision Date2020-11-24
PMAP190018
SupplementS008
Advisory CommitteeOphthalmic
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address Alcon Research, Ltd. 6201 South Freeway, Tc-467 forth Worth, TX 76134

Supplemental Filings

Supplement NumberDateSupplement Type
P190018Original Filing
S021 2022-11-22 30-day Notice
S020 2022-04-22 30-day Notice
S019 2022-04-06 30-day Notice
S018
S017 2021-12-02 30-day Notice
S016 2021-11-30 30-day Notice
S015 2021-11-23 30-day Notice
S014 2021-11-05 30-day Notice
S013
S012
S011 2021-03-26 30-day Notice
S010 2021-02-22 Normal 180 Day Track No User Fee
S009 2020-12-14 Real-time Process
S008 2020-10-30 30-day Notice
S007 2020-10-16 30-day Notice
S006 2020-08-31 30-day Notice
S005
S004 2020-05-19 30-day Notice
S003
S002
S001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.